GlassScriptPhysician profile
Richard W Gates
NPI 1306812078
$2,391.04
in general payments reported to CMS, 2019-2025
35 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $94.15 · 2021: $222 · 2022: $789 · 2023: $367 · 2024: $211 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $741.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $516.66 | 2019-2025 | |
| Hologic Sales and Service, LLC | $359.82 | 2019-2024 | Fluent Fluid Management System, Novasure, Acessa Provu System |
| Mayne Pharma Commercial LLC | $132.06 | 2021-2023 | |
| Coopersurgical, INC. | $113.77 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $92.47 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $81.05 | 2019-2025 | |
| Aspira Women'S Health INC | $80.77 | 2022-2024 | Ova1 |
| Agile Therapeutics, INC. | $79.72 | 2021-2022 | |
| Astellas Pharma US INC | $76.60 | 2019-2025 | Veozah |
| Myovant Sciences INC. | $76.18 | 2021-2022 | |
| Avion Pharmaceuticals | $66.29 | 2021-2022 | |
| Therapeuticsmd, INC. | $66.24 | 2019-2022 | |
| Medtronic, INC. | $61.58 | 2022 | |
| Duchesnay USA Incorporated | $61.56 | 2019 | |
| Organon LLC | $56.25 | 2025 | Nexplanon |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $54.78 | 2021-2025 | Slynd |
| Sumitomo Pharma America, INC. | $36.69 | 2023 | Myfembree |
| Amag Pharmaceuticals, INC. | $32.63 | 2019 | |
| Axonics, INC. | $31.14 | 2022-2023 | Axonics, Bulkamid |
| Novo Nordisk INC | $28.49 | 2019-2023 | Wegovy |
| Vertical Pharmaceuticals, LLC | $26.22 | 2019 | |
| Avanos Medical | $26.15 | 2022 | |
| Biogen, INC. | $25.37 | 2024 | Zurzuvae |
| Minerva Surgical, INC | $25.35 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.95 | 2019 | |
| Mylan Pharmaceuticals INC. | $23.98 | 2021 | |
| Smith+Nephew, INC. | $18.09 | 2025 | "Acticoat 4"" X 4""", Renasys Touch, Pico |
| Exact Sciences Corporation | $17.17 | 2025 | The Cologuard Plus Collection Kit |
| Channel Medsystems, INC. | $16.46 | 2023 | |
| Ethicon US, LLC | $16.36 | 2019 | |
| Shield Therapeutics INC | $14.08 | 2023 | Accrufer |
| Covidien LP | $13.95 | 2019 | |
| Meditrina | $13.40 | 2023 | |
| Lupin INC. | $12.63 | 2019 | |
| Boston Scientific Corporation | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Gates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.